These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34662226)

  • 1. Capsid-Engineering for Central Nervous System-Directed Gene Therapy with Adeno-Associated Virus Vectors.
    Macdonald J; Marx J; Büning H
    Hum Gene Ther; 2021 Oct; 32(19-20):1096-1119. PubMed ID: 34662226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus (AAV) capsid engineering in liver-directed gene therapy.
    Rodríguez-Márquez E; Meumann N; Büning H
    Expert Opin Biol Ther; 2021 Jun; 21(6):749-766. PubMed ID: 33331201
    [No Abstract]   [Full Text] [Related]  

  • 3. Adeno-Associated Virus Vector Design-Moving the Adeno-Associated Virus to a Bioengineered Therapeutic Nanoparticle.
    Jäschke N; Büning H
    Hematol Oncol Clin North Am; 2022 Aug; 36(4):667-685. PubMed ID: 35778330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering adeno-associated virus vectors for gene therapy.
    Li C; Samulski RJ
    Nat Rev Genet; 2020 Apr; 21(4):255-272. PubMed ID: 32042148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering the AAV capsid to optimize vector-host-interactions.
    Büning H; Huber A; Zhang L; Meumann N; Hacker U
    Curr Opin Pharmacol; 2015 Oct; 24():94-104. PubMed ID: 26302254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges.
    Kang L; Jin S; Wang J; Lv Z; Xin C; Tan C; Zhao M; Wang L; Liu J
    J Control Release; 2023 Mar; 355():458-473. PubMed ID: 36736907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
    Shi W; Arnold GS; Bartlett JS
    Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver directed adeno-associated viral vectors to treat metabolic disease.
    Chuecos MA; Lagor WR
    J Inherit Metab Dis; 2024 Jan; 47(1):22-40. PubMed ID: 37254440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy.
    Liu Y; Siriwon N; Rohrs JA; Wang P
    Curr Pharm Des; 2015; 21(22):3248-56. PubMed ID: 26027561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy.
    Wagner HJ; Weber W; Fussenegger M
    Adv Sci (Weinh); 2021 May; 8(9):2004018. PubMed ID: 33977059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation AAV vectors-do not judge a virus (only) by its cover.
    Domenger C; Grimm D
    Hum Mol Genet; 2019 Oct; 28(R1):R3-R14. PubMed ID: 31261383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution of Adeno-Associated Virus Gene Therapy Following Cerebrospinal Fluid-Directed Administration.
    Chen X; Lim DA; Lawlor MW; Dimmock D; Vite CH; Lester T; Tavakkoli F; Sadhu C; Prasad S; Gray SJ
    Hum Gene Ther; 2023 Feb; 34(3-4):94-111. PubMed ID: 36606687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
    Muzyczka N; Warrington KH
    Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV capsid design: A Goldilocks challenge.
    Zolotukhin S; Vandenberghe LH
    Trends Mol Med; 2022 Mar; 28(3):183-193. PubMed ID: 35093287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus vectors and neurological gene therapy.
    Ojala DS; Amara DP; Schaffer DV
    Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the adeno-associated viral vector system: a brief summary.
    Hacker U; Büning H
    Ther Deliv; 2011 Aug; 2(8):967-70. PubMed ID: 22826865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
    Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.